Arcus South East Asia
Kuala Lumpurarcusinvest.com
Overview
Arcus South East Asia is the Malaysian office of Arcus Group, a Pan-Asian fund management company that makes disciplined and active investments in undervalued equities, with a specialization in the Japanese market.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rege Nephro Co., Ltd. | Jul 2026 | Debt | Co-investor |
| Metagen Therapeutics, Inc. | Feb 2026 | Series B | Co-investor |
| Metagen Therapeutics, Inc. | Sep 2025 | Series B | Co-investor |
| Heartseed | May 2023 | Series D | Co-investor |
| Heartseed | May 2023 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
